2004Journal of OncologyRequires access

The Role of CA15-3 and CEA in Follow-up for Post Operative Patients with Breast Cancer

Kangsheng Gu

Open publisher page 0 citations

Abstract

To investigate the role of CA15-3 and CEA in follow-up for post-operation cases with breast cancer. Serum CA15-3 and CEA were examined by radio-immune method in 88 cases with breast cancer after operation. CA15-3 was not significant difference between patients with cancer recurrence and with recurrence (P0.1), while significant difference was observed by CEA (P0.001). There were no significance for the diagnosis of local tumor recurrence or systemic metastasis by detecting both markers in these patients(P0.1). [Conclusion] CEA maybe a routine index for follow-up in patients with breast cancer, but not CA15-3.

About this research paper

What this paper is about

To investigate the role of CA15-3 and CEA in follow-up for post-operation cases with breast cancer. Serum CA15-3 and CEA were examined by radio-immune method in 88 cases with breast cancer after operation. CA15-3 was not significant difference between patients with cancer recurrence and with recurrence (P0.1), while significant difference was observed by CEA (P0.001). There were no significance for the diagnosis of local tumor recurrence or systemic metastasis by detecting both markers in these patients(P0.1). [Conclusion] CEA maybe a routine index for follow-up in patients with breast cancer, but not CA15-3.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To investigate the role of CA15-3 and CEA in follow-up for post-operation cases with breast cancer. Serum CA15-3 and CEA were examined by radio-immune method in 88 cases with breast cancer after operation. CA15-3 was not significant difference between patients with cancer recurrence and with recurrence (P0.1), while significant difference was observed by CEA (P0.001). There were no significance for the diagnosis of local tumor recurrence or systemic metastasis by detecting both markers in these patients(P0.1). [Conclusion] CEA maybe a routine index for follow-up in patients with breast cancer, but not CA15-3.

Key concepts: Medicine, Breast cancer, CA15-3, Oncology, Internal medicine, Cancer, Metastasis, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
The Role of CA15-3 and CEA in Follow-up for Post Operative Patients with Breast Cancer — Research Paper | ScholarLens